UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000013366
Receipt No. R000015393
Official scientific title of the study Features of responders to Tolvaptan in CKD patients
Date of disclosure of the study information 2014/03/07
Last modified on 2016/09/08 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Features of responders to Tolvaptan in CKD patients
Title of the study (Brief title) CKD-FORT study
Region
Japan

Condition
Condition Chronic kidney disease
Classification by specialty
Medicine in general Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the short-term and long-term impact of Tolvaptan in advanced stage CKD patients by observing the efficacy of the drug and other selected parameters.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes Urine output after initiating Tolvaptan
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Inclusion criteria are as follows: CKD 4 and 5 patients with volume overload and insufficient response to loop or other diuretic agents; older than 20 years old; being able to express clear understanding of the purpose of the study; being able to complete a written informed consent.
Patients gender will not be restricted. Informed consent can be obtained by families for those who are not able to write it by themselves.
Key exclusion criteria 1. Previous history of tolvaptan use
2. Contraindication for tolvaptan
3. Unable to take an oral medication
4. Requiring immediate dialysis therapy
5. Pregnant or wish to be pregnant
7. History of major surgery within 60 days
8. History of acute myocardial infarction within 30 days
9. Severe hepatic failure or heart disease
10. Other cases which treating physicians regards as inappropriate for a candidate
Target sample size 75

Research contact person
Name of lead principal investigator Sei Sasaki
Organization Tokyo Medical and Dental University
Division name Department of Nephrology
Address 1-5-45 Yushima Bunkyo-ku Tokyo, Japan
TEL 03-5803-5214
Email tokado.kid@tmd.ac.jp

Public contact
Name of contact person Tomokazu Okado
Organization Tokyo Medical and Dental University
Division name Department of Chronic Kidney Disease
Address 1-5-45 Yushima Bunkyo-ku Tokyo, Japan
TEL 03-5803-5214
Homepage URL http://www.tmd.ac.jp/grad/kid/kid-J.htm
Email tokado.kid@tmd.ac.jp

Sponsor
Institute Department of Nephrology, Tokyo Medical and Dental University
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Affiliated hospitals of Tokyo Medical and Dental University Hospital
Name of secondary funder(s) none

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京医科歯科大学病院(東京都)

Other administrative information
Date of disclosure of the study information
2014 Year 03 Month 07 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2013 Year 12 Month 25 Day
Anticipated trial start date
2013 Year 12 Month 25 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information No other related information

Management information
Registered date
2014 Year 03 Month 07 Day
Last modified on
2016 Year 09 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015393